Main > A1. CORP. INDEX. E-Em > Eagle Pharmaceuticals Inc./P C2

This data is not available for free

Eagle Pharmaceuticals Inc./P C2's subsections
2014. 07.23. Malignant Hyperthermia
2015. 09.29. Onco.>Bendamustine
2015. 12.24. Onco.>DoceTaxel USA>OK
2016. 02.02. Onco.>DoceTaxel USA>La
2016. 06.27. CEO Scott Tarriff
2018. 03.27. Patent
2020. 02.10. Onco.>Lung C. USA>OK
2021. 08.31. Patent
2022. 02.01. Onco.>Lung C. USA>Laun
2022. 03.28. Acq. Acacia Pharma Ltd
2022. 06.09. Acq. Acacia Pharma Ltd
2022. 12.19. Onco.>Lung C. USA>OK
Web-Site

Eagle Pharmaceuticals Inc./P C2's products
This section has no products